Published in Transplantation on August 27, 2010
Long-term outcomes of pre-emptive valganciclovir compared with valacyclovir prophylaxis for prevention of cytomegalovirus in renal transplantation. J Am Soc Nephrol (2012) 2.16
Cytomegalovirus infection in transplant recipients. Clinics (Sao Paulo) (2015) 0.80
Syndrome of rapid-onset end-stage renal disease in two consecutive renal transplant recipients. Indian J Nephrol (2013) 0.79
Use of leflunomide in renal transplant recipients with ganciclovir-resistant/refractory cytomegalovirus infection: a case series from the University of Chicago. Case Rep Nephrol Dial (2015) 0.78
Randomized trial of valganciclovir versus valacyclovir prophylaxis for prevention of cytomegalovirus in renal transplantation. Clin J Am Soc Nephrol (2014) 0.76
Prevention of cytomegalovirus in organ transplant recipients: cross roads between antiviral and antitumor immunity. Transplantation (2010) 0.75
KDIGO Clinical Practice Guideline on the Evaluation and Care of Living Kidney Donors. Transplantation (2017) 0.75
Potential role of human cytomegalovirus and p53 interaction in coronary restenosis. Science (1994) 4.94
Rabbit antithymocyte globulin versus basiliximab in renal transplantation. N Engl J Med (2006) 4.79
Seventh report of the Joint National Committee on the Prevention, Detection, Evaluation, and Treatment of High Blood Pressure (JNC 7): resetting the hypertension sails. Hypertension (2003) 3.18
Oral valganciclovir is noninferior to intravenous ganciclovir for the treatment of cytomegalovirus disease in solid organ transplant recipients. Am J Transplant (2007) 3.02
Improvement in long-term renal graft survival due to CMV prophylaxis with oral ganciclovir: results of a randomized clinical trial. Am J Transplant (2008) 2.07
Cytomegalovirus-induced gammadelta T cells associate with reduced cancer risk after kidney transplantation. J Am Soc Nephrol (2009) 1.72
Creatinine filtration, secretion and excretion during progressive renal disease. Modification of Diet in Renal Disease (MDRD) Study Group. Kidney Int Suppl (1989) 1.66
A randomized, double-blinded comparison of Thymoglobulin versus Atgam for induction immunosuppressive therapy in adult renal transplant recipients. Transplantation (1999) 1.62
Cytomegalovirus in renal transplantation. J Am Soc Nephrol (2001) 1.60
Valganciclovir as treatment for cytomegalovirus disease in solid organ transplant recipients. Clin Infect Dis (2008) 1.58
Impact of early cytomegalovirus infection and disease on long-term recipient and kidney graft survival. Kidney Int (2004) 1.57
Prophylactic versus preemptive oral valganciclovir for the management of cytomegalovirus infection in adult renal transplant recipients. Am J Transplant (2006) 1.52
Valganciclovir preemptive therapy for the prevention of cytomegalovirus disease in high-risk seropositive solid-organ transplant recipients. Transplantation (2006) 1.49
Single-dose pharmacokinetics of valganciclovir in HIV- and CMV-seropositive subjects. J Clin Pharmacol (1999) 1.46
The impact of cytomegalovirus infection and disease on rejection episodes in renal allograft recipients. Am J Transplant (2002) 1.36
The pathogenesis and clinical management of cytomegalovirus infection in the organ transplant recipient: the end of the 'silo hypothesis'. Curr Opin Infect Dis (2007) 1.36
Viral infection in the renal transplant recipient. J Am Soc Nephrol (2005) 1.29
Symptomatic cytomegalovirus disease in the cytomegalovirus antibody seropositive renal transplant recipient treated with OKT3. Transplantation (1992) 1.16
Asymptomatic cytomegalovirus infection is associated with increased risk of new-onset diabetes mellitus and impaired insulin release after renal transplantation. Diabetologia (2004) 1.15
Management of cardiovascular disease in renal transplant recipients. Clin J Am Soc Nephrol (2008) 1.03
Long-term results of rabbit antithymocyte globulin and basiliximab induction. N Engl J Med (2008) 1.03
A prospective, randomized, double-blinded comparison of thymoglobulin versus Atgam for induction immunosuppressive therapy: 10-year results. Transplantation (2008) 0.99
Control of cytomegalovirus-associated morbidity in renal transplant patients using intensive monitoring and either preemptive or deferred therapy. J Am Soc Nephrol (1997) 0.98
CMV infection is associated with transplant renal artery stenosis. QJM (1998) 0.97
Prophylactic oral ganciclovir compared with deferred therapy for control of cytomegalovirus in renal transplant recipients. Transplantation (1997) 0.95
Effect of cytomegalovirus viremia on subclinical rejection or interstitial fibrosis and tubular atrophy in protocol biopsy at 3 months in renal allograft recipients managed by preemptive therapy or antiviral prophylaxis. Transplantation (2009) 0.93
Cytomegalovirus disease after prophylaxis with oral ganciclovir in renal transplantation: the importance of HLA-DR matching. J Am Soc Nephrol (2003) 0.90
Preemptive therapy versus universal prophylaxis with ganciclovir for cytomegalovirus in solid organ transplant recipients. Clin Infect Dis (2001) 0.88
International trial of the Edmonton protocol for islet transplantation. N Engl J Med (2006) 13.43
Identification of a novel polyomavirus from patients with acute respiratory tract infections. PLoS Pathog (2007) 8.01
Valganciclovir for symptomatic congenital cytomegalovirus disease. N Engl J Med (2015) 3.75
Racial variation in medical outcomes among living kidney donors. N Engl J Med (2010) 3.60
Polyomavirus-associated nephropathy in renal transplantation: interdisciplinary analyses and recommendations. Transplantation (2005) 3.57
Expanding the evidence base in transplantation: the complementary roles of randomized controlled trials and outcomes research. Transplantation (2008) 3.43
Diagnosis and management of tickborne rickettsial diseases: Rocky Mountain spotted fever, ehrlichioses, and anaplasmosis--United States: a practical guide for physicians and other health-care and public health professionals. MMWR Recomm Rep (2006) 3.32
Incidence of BK with tacrolimus versus cyclosporine and impact of preemptive immunosuppression reduction. Am J Transplant (2005) 2.76
Conversion from calcineurin inhibitors to sirolimus maintenance therapy in renal allograft recipients: 24-month efficacy and safety results from the CONVERT trial. Transplantation (2009) 2.33
Virulence gene expression in human community-acquired Staphylococcus aureus infection. J Infect Dis (2009) 2.24
Awareness of kidney disease and relationship to end-stage renal disease and mortality. Am J Med (2012) 2.24
Incidence and cost of new onset diabetes mellitus among U.S. wait-listed and transplanted renal allograft recipients. Am J Transplant (2003) 2.22
Donor origin of BK virus in renal transplantation and role of HLA C7 in susceptibility to sustained BK viremia. Am J Transplant (2005) 2.19
Sensitivity of billing claims for cardiovascular disease events among kidney transplant recipients. Clin J Am Soc Nephrol (2009) 2.17
Bone morphogenetic proteins in vascular calcification. Circ Res (2005) 2.12
Detection of newly described astrovirus MLB1 in stool samples from children. Emerg Infect Dis (2009) 2.02
MultiCode-PLx system for multiplexed detection of seventeen respiratory viruses. J Clin Microbiol (2007) 1.98
Incidence and predictors of myocardial infarction after kidney transplantation. J Am Soc Nephrol (2004) 1.93
Effectiveness of measures to eradicate Staphylococcus aureus carriage in patients with community-associated skin and soft-tissue infections: a randomized trial. Infect Control Hosp Epidemiol (2011) 1.92
Prevalence of and risk factors for community-acquired methicillin-resistant and methicillin-sensitive staphylococcus aureus colonization in children seen in a practice-based research network. Pediatrics (2008) 1.85
Nomogram for predicting the likelihood of delayed graft function in adult cadaveric renal transplant recipients. J Am Soc Nephrol (2003) 1.77
Bariatric surgery among kidney transplant candidates and recipients: analysis of the United States renal data system and literature review. Transplantation (2009) 1.75
Discovery of STL polyomavirus, a polyomavirus of ancestral recombinant origin that encodes a unique T antigen by alternative splicing. Virology (2012) 1.75
contribution of genetically restricted, methicillin-susceptible strains to the ongoing epidemic of community-acquired Staphylococcus aureus infections. Clin Infect Dis (2009) 1.74
Living donation decision making: recipients' concerns and educational needs. Prog Transplant (2006) 1.73
Canadian society of transplantation consensus workshop on cytomegalovirus management in solid organ transplantation final report. Am J Transplant (2005) 1.73
Nephrogenic systemic fibrosis: a mysterious disease in patients with renal failure--role of gadolinium-based contrast media in causation and the beneficial effect of intravenous sodium thiosulfate. Clin J Am Soc Nephrol (2007) 1.68
Genotype prevalence and risk factors for severe clinical adenovirus infection, United States 2004-2006. Clin Infect Dis (2007) 1.63
Atypical avian influenza (H5N1). Emerg Infect Dis (2004) 1.60
Sequence analysis of the human virome in febrile and afebrile children. PLoS One (2012) 1.56
Portal vein thrombosis complicating islet transplantation in a recipient with the Factor V Leiden mutation. Transplantation (2004) 1.51
Genome sequence of enterovirus D68 from St. Louis, Missouri, USA. Emerg Infect Dis (2015) 1.49
Clinical and epidemiologic characterization of WU polyomavirus infection, St. Louis, Missouri. Emerg Infect Dis (2007) 1.48
Race, Relationship and Renal Diagnoses After Living Kidney Donation. Transplantation (2015) 1.45
Rising rates of macrolide-resistant Mycoplasma pneumoniae in the central United States. Pediatr Infect Dis J (2012) 1.44
Acute renal insufficiency during telavancin therapy in clinical practice. J Antimicrob Chemother (2011) 1.43
Will dialysis prevent the development of nephrogenic systemic fibrosis after gadolinium-based contrast administration? AJR Am J Roentgenol (2007) 1.42
No independent association of serum phosphorus with risk for death or progression to end-stage renal disease in a large screen for chronic kidney disease. Kidney Int (2013) 1.38
Multiplex, quantitative, real-time PCR assay for cytomegalovirus and human DNA. J Clin Microbiol (2002) 1.38
Skin infection in children colonized with community-associated methicillin-resistant Staphylococcus aureus. J Infect (2009) 1.37
BK virus nephropathy and kidney transplantation. Clin J Am Soc Nephrol (2007) 1.36
Mupirocin resistance in patients colonized with methicillin-resistant Staphylococcus aureus in a surgical intensive care unit. Clin Infect Dis (2007) 1.36
Cost-effectiveness of extending Medicare coverage of immunosuppressive medications to the life of a kidney transplant. Am J Transplant (2004) 1.33
Detection of severe human metapneumovirus infection by real-time polymerase chain reaction and histopathological assessment. J Infect Dis (2005) 1.31
Association between lack of health insurance and risk of death and ESRD: results from the Kidney Early Evaluation Program (KEEP). Am J Kidney Dis (2013) 1.29
CKD awareness in the United States: the Kidney Early Evaluation Program (KEEP). Am J Kidney Dis (2008) 1.26
Clinical, microbiologic, and genetic determinants of persistent methicillin-resistant Staphylococcus aureus bacteremia. Diagn Microbiol Infect Dis (2010) 1.26
BK virus antibody titers and intensity of infections after renal transplantation. J Clin Virol (2008) 1.25
Renal osteodystrophy, phosphate homeostasis, and vascular calcification. Semin Dial (2007) 1.24
Detection of viruses in young children with fever without an apparent source. Pediatrics (2012) 1.23
Consistency of racial variation in medical outcomes among publicly and privately insured living kidney donors. Transplantation (2014) 1.22
The expanded criteria donor dilemma in cadaveric renal transplantation. Transplantation (2003) 1.22
Delivery patterns of recommended chronic kidney disease care in clinical practice: administrative claims-based analysis and systematic literature review. Clin Exp Nephrol (2008) 1.21
Human polyoma viruses and disease with emphasis on clinical BK and JC. J Clin Virol (2010) 1.17
Emerging view of the human virome. Transl Res (2012) 1.17
Serum sickness after treatment with rabbit antithymocyte globulin in kidney transplant recipients with previous rabbit exposure. Am J Kidney Dis (2009) 1.15
Astrovirus MLB2 viremia in febrile child. Emerg Infect Dis (2011) 1.14
Mycophenolate mofetil dose reductions and discontinuations after gastrointestinal complications are associated with renal transplant graft failure. Transplantation (2006) 1.13
Agreement of immunosuppression regimens described in Medicare pharmacy claims with the Organ Procurement and Transplantation Network survey. J Am Soc Nephrol (2006) 1.13
Invasive honeysuckle eradication reduces tick-borne disease risk by altering host dynamics. Proc Natl Acad Sci U S A (2010) 1.12
Gene expression profiles in febrile children with defined viral and bacterial infection. Proc Natl Acad Sci U S A (2013) 1.11
Incidence, predictors, and associated outcomes of atrial fibrillation after kidney transplantation. Clin J Am Soc Nephrol (2005) 1.11
Reversible cystoid macular edema secondary to fingolimod in a renal transplant recipient. Arch Ophthalmol (2008) 1.09
De novo congestive heart failure after kidney transplantation: a common condition with poor prognostic implications. Am J Kidney Dis (2005) 1.09
Five-year follow up of thymoglobulin versus ATGAM induction in adult renal transplantation. Transplantation (2004) 1.07
Blood meal analysis to identify reservoir hosts for Amblyomma americanum ticks. Emerg Infect Dis (2010) 1.07
Diabetic complications associated with new-onset diabetes mellitus in renal transplant recipients. Transplantation (2007) 1.06
Detection of respiratory viruses and the associated chemokine responses in serious acute respiratory illness. Thorax (2010) 1.05
Metagenomic analysis of double-stranded DNA viruses in healthy adults. BMC Biol (2014) 1.05
Empiric first-line antibiotic treatment of acute otitis in the era of the heptavalent pneumococcal conjugate vaccine. Pediatrics (2006) 1.05
Early clinical complications after ABO-incompatible live-donor kidney transplantation: a national study of Medicare-insured recipients. Transplantation (2014) 1.04
Genetic variability of human metapneumovirus infection: evidence of a shift in viral genotype without a change in illness. J Infect Dis (2005) 1.04
Novel methods for tracking long-term maintenance immunosuppression regimens. Clin J Am Soc Nephrol (2007) 1.04
Correlation of cerebrospinal fluid (CSF) cell counts and elevated CSF protein levels with enterovirus reverse transcription-PCR results in pediatric and adult patients. J Clin Microbiol (2004) 1.03
Panton-Valentine Leukocidin-positive methicillin-resistant Staphylococcus aureus lung infection in patients with cystic fibrosis. Chest (2007) 1.03
The natural history of contemporary Staphylococcus aureus nasal colonization in community children. Pediatr Infect Dis J (2011) 1.03
Inhibitory interactions between BK and JC virus among kidney transplant recipients. J Am Soc Nephrol (2011) 1.03
Long-term results of rabbit antithymocyte globulin and basiliximab induction. N Engl J Med (2008) 1.03
A significant role for histocompatibility in human islet transplantation. Transplantation (2006) 1.02
Variations in the risk for cerebrovascular events after kidney transplant compared with experience on the waiting list and after graft failure. Clin J Am Soc Nephrol (2008) 1.02
The role of tacrolimus in renal transplantation. Expert Opin Pharmacother (2008) 1.02
Short course induction immunosuppression with thymoglobulin for renal transplant recipients. Transplantation (2002) 1.02
Physician utilization, risk-factor control, and CKD progression among participants in the Kidney Early Evaluation Program (KEEP). Am J Kidney Dis (2012) 1.01
Review of cytomegalovirus infection findings with mammalian target of rapamycin inhibitor-based immunosuppressive therapy in de novo renal transplant recipients. Transplantation (2012) 1.01
Comparison of the Eragen Multi-Code Respiratory Virus Panel with conventional viral testing and real-time multiplex PCR assays for detection of respiratory viruses. J Clin Microbiol (2010) 1.01
The life-years saved by a deceased organ donor. Am J Transplant (2005) 1.00
The association of cytomegalovirus sero-pairing with outcomes and costs following cadaveric renal transplantation prior to the introduction of oral ganciclovir CMV prophylaxis. Am J Transplant (2003) 0.99
The importance of early treatment with doxycycline in human ehrlichiosis. Medicine (Baltimore) (2008) 0.99
A prospective, randomized, double-blinded comparison of thymoglobulin versus Atgam for induction immunosuppressive therapy: 10-year results. Transplantation (2008) 0.99
Kidney transplant Medicare payments and length of stay: associations with comorbidities and organ quality. Arch Med Sci (2011) 0.99
Long-term outcome of gastrointestinal complications in renal transplant patients treated with mycophenolate mofetil. Transpl Int (2004) 0.97
Intrinsic reduced susceptibility of serotype 6 Streptococcus pyogenes to fluoroquinolone antibiotics. J Infect Dis (2005) 0.97
CMV infection of the renal allograft is much more common than the pathology indicates: a retrospective analysis of qualitative and quantitative buffy coat CMV-PCR, renal biopsy pathology and tissue CMV-PCR. Nephrol Dial Transplant (2003) 0.96